Pulmonx 

Yahoo Finance • 17 days ago

Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline

Earnings Call Insights: Pulmonx Corporation (LUNG) Q3 2025 MANAGEMENT VIEW * CEO Glendon French announced his return to the CEO role and highlighted the reappointment of Derrick Sung as COO and CFO, citing Sung's "broad and diverse ski... Full story

Yahoo Finance • last month

Pulmonx reports Q3 Preliminary results

* Pulmonx press release [https://seekingalpha.com/pr/20280941-pulmonx-announces-management-transition-and-preliminary-third-quarter-2025-revenue] (NASDAQ:LUNG [https://seekingalpha.com/symbol/LUNG]): Q3 revenue expected to be approximate... Full story

Yahoo Finance • last month

Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates

(RTTNews) - Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity. Pulmonx Corp. (LUNG) surged 33.33% to $2.08 as of 9:... Full story

Yahoo Finance • last month

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Officer, appointed Chief Operating Office... Full story

Yahoo Finance • last month

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial re... Full story

Yahoo Finance • 3 months ago

Pulmonx to Participate in September Investor Conferences

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at t... Full story

Yahoo Finance • 4 months ago

Discover the top movers in Thursday's pre-market session.

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMME... Full story

Yahoo Finance • 4 months ago

Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns

Investing.com - Piper Sandler downgraded Pulmonx Corp . (NASDAQ:LUNG) from Overweight to Neutral on Thursday, while significantly reducing its price target to $2.50 from $9.00 following the company’s second-quarter report. The stock, whic... Full story

Yahoo Finance • 4 months ago

Pulmonx revises 2025 revenue target to $90M–$92M as U.S. initiatives ramp slower, while international growth accelerates

Earnings Call Insights: Pulmonx Corporation (LUNG) Q2 2025 MANAGEMENT VIEW * Steven S. Williamson, CEO, highlighted second quarter 2025 revenue of $23.9 million and emphasized international performance, stating, "Our international busi... Full story

Yahoo Finance • 4 months ago

Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains

Pulmonx Corp reported its Q2 2025 earnings, revealing a net loss of $0.38 per share, slightly better than the forecasted loss of $0.40. The company recorded revenue of $23.9 million, surpassing expectations of $23.47 million. Following the... Full story

Yahoo Finance • 4 months ago

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at... Full story

Yahoo Finance • 4 months ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

REDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial re... Full story

Yahoo Finance • 6 months ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at... Full story

Yahoo Finance • 7 months ago

Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025

REDWOOD CITY, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fi... Full story

Yahoo Finance • 9 months ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth q... Full story

Yahoo Finance • 10 months ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fires... Full story

Yahoo Finance • 10 months ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

REDWOOD CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fou... Full story

Yahoo Finance • 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fires... Full story

Yahoo Finance • 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

REDWOOD CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the thi... Full story

Yahoo Finance • 2 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Derrick Sung steps down from his position as Chief Financial Officer to pursue another opportunity; John McKune appointed Interim Chief Financial OfficerPreliminary, unaudited third quarter 2023 revenue expected to be approximately $17.6 m... Full story